サンプル依頼リスト カート
  • English
  • Korean
市場調査レポート
商品コード
1535556

アジア太平洋のタンパク質発現市場：用途別、エンドユーザー別、製品別、発現システム別、国別 - 分析と予測（2023年～2033年）

Asia-Pacific Protein Expression Market: Focus on Application, End User, Product, Expression System, and Country - Analysis and Forecast, 2023-2033

出版日
発行
BIS Research
ページ情報
英文 77 Pages
納期
1～5営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
アジア太平洋のタンパク質発現市場：用途別、エンドユーザー別、製品別、発現システム別、国別 - 分析と予測（2023年～2033年）
出版日: 2024年08月16日
発行: BIS Research
ページ情報: 英文 77 Pages
納期: 1～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

アジア太平洋のタンパク質発現の市場規模は、2023年に5億3,060万米ドルとなりました。

同市場は、2023年から2033年にかけて13.05%のCAGRで拡大し、2033年には18億980万米ドルに達すると予測されています。タンパク質の発現は、細胞や生物内でタンパク質が生産されるプロセスです。これには、タンパク質の合成、修飾、調節が含まれ、これらはすべてDNAに格納された遺伝情報によって指示されます。複雑な構造と多様な機能を持つタンパク質は、生命を維持し、様々な生物学的プロセスを可能にするために極めて重要です。

主要市場統計
予測期間 2023年～2033年
2023年の評価 5億3,060万米ドル
2033年の予測 18億980万米ドル
CAGR 13.05%

アジア太平洋のタンパク質発現市場は、バイオテクノロジーの著しい進歩や、研究、治療、産業などさまざまな用途における組み換えタンパク質の需要増加を背景に、急速に拡大しています。タンパク質発現、すなわち細胞がタンパク質を産生し、折り畳み、組み立てるプロセスは、生物学的機能を理解し、新薬を開発する上で極めて重要であり、特に慢性疾患の蔓延が増加していることを考慮すると、その需要は極めて大きいです。この需要により、バイオ医薬品業界は革新的なソリューションとより効率的な製造方法の開発に取り組んでいます。

無細胞タンパク質発現システムや高度な発現ベクターなどの技術の進歩は、タンパク質の生産効率と収率を高め、市場を前進させています。アジア太平洋地域は研究開発（R&D）への投資増加の恩恵を受けており、主要な業界プレーヤーはヘルスケアとバイオテクノロジー分野の多様なニーズに応える新製品とサービスの立ち上げに注力しています。さらに、学術機関、研究機関、バイオテクノロジー企業間の連携がイノベーションを促進し、研究の臨床応用への移行を加速しています。

さらに、個別化医療が重視されるようになり、診断や治療におけるタンパク質の利用が増加していることも、市場成長の大きな促進要因となっています。こうした原動力により、アジア太平洋のタンパク質発現市場は今後数年間で大きく成長する態勢が整っており、世界のバイオテクノロジー情勢における重要な地域として位置付けられています。

当レポートでは、アジア太平洋のタンパク質発現市場について調査し、市場の概要とともに、用途別、エンドユーザー別、製品別、発現システム別、国別の動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

エグゼクティブサマリー

第1章 市場

  • 動向：現在および将来の影響評価
  • サプライチェーンの概要
  • 研究開発レビュー
  • 規制状況
  • 主要な世界的出来事の影響分析-COVID-19
  • 市場参入障壁と機会
  • 市場力学の概要

第2章 地域

  • 地域別概要
  • 促進要因と抑制要因
  • アジア太平洋

第3章 市場-競合ベンチマーキングと企業プロファイル

  • 今後の見通し
  • 企業評価
  • 市場エコシステムと主要参入企業
    • GenCefe Co., Ltd.
    • Takara Bio Inc.

第4章 調査手法

図表

List of Figures

  • Figure 1: Region with the Largest Share of Market, 2023, 2027, and 2033
  • Figure 2: Asia-Pacific Protein Expression Market (by Application), $Million, 2023, 2027, and 2033
  • Figure 3: Asia-Pacific Protein Expression Market (by End User), $Million, 2023, 2027, and 2033
  • Figure 4: Asia-Pacific Protein Expression Market (by Product), $Million, 2023 and 2033
  • Figure 5: Asia-Pacific Protein Expression Market (by Expression System), $Million, 2023 and 2033
  • Figure 6: Key Events to Keep Track of within the Protein Expression Market
  • Figure 7: Advantages of Using Automation for Protein Expression
  • Figure 8: Supply Chain and Risks within the Supply Chain
  • Figure 9: Protein Expression Market (by Country), January 2021-December 2023
  • Figure 10: Patents Filed in Protein Expression Market (by Year), January 2021-December 2023
  • Figure 11: Impact of COVID-19 on Protein Expression Market
  • Figure 12: Impact Analysis of Market Navigating Factors, 2023-2033
  • Figure 13: Recently Launched Protein Biologics, their Indications, and Manufacturers
  • Figure 14: Total Pharmaceutical Research and Development Pipeline Size (by Year), 2010-2023
  • Figure 15: All Protein Synthesis Funding between 2022 and 2023
  • Figure 16: Timeline of Biologics Clinical Trials
  • Figure 17: Challenges at each of the Protein Expression Steps
  • Figure 18: Timeline of Microfluidics over the Years
  • Figure 19: Examples of Increasing Awareness with Respect to Proteomics in India and China
  • Figure 20: Number of Authorized Biologics in China Compared to the U.S. (2016-2020)
  • Figure 21: China Protein Expression Market, $Million, 2022-2033
  • Figure 22: India Protein Expression Market, $Million, 2022-2033
  • Figure 23: Australia Protein Expression Market, $Million, 2022-2033
  • Figure 24: Japan Protein Expression Market, $Million, 2022-2033
  • Figure 25: South Korea Protein Expression Market, $Million, 2022-2033
  • Figure 26: Rest-of-Asia-Pacific Protein Expression Market, $Million, 2022-2033
  • Figure 27: Strategic Initiatives, 2021-2023
  • Figure 28: Share of Strategic Initiatives, 2021-2023
  • Figure 29: Data Triangulation
  • Figure 30: Top-Down and Bottom-Up Approach
  • Figure 31: Assumptions and Limitations

List of Tables

  • Table 1: Asia-Pacific Protein Expression Market Snapshot
  • Table 2: Opportunities across Regions
  • Table 3: Recent Advancements in Protein Engineering
  • Table 4: Protein Expression Market, Product Benchmarking by Expression System
  • Table 5: Examples of Five Regulatory Bodies and Recombinant Protein
  • Table 6: Protein Expression (by Region), $Million, 2022-2033
  • Table 7: Asia-Pacific Protein Expression Market (by Application), $Million, 2022-2033
  • Table 8: Asia-Pacific Protein Expression Market (by End User), $Million, 2022-2033
  • Table 9: Asia-Pacific Protein Expression Market (by Product), $Million, 2022-2033
  • Table 10: Asia-Pacific Protein Expression Market (by Expression System), $Million, 2022-2033
  • Table 11: China Protein Expression Market (by Application), $Million, 2022-2033
  • Table 12: China Protein Expression Market (by End User), $Million, 2022-2033
  • Table 13: China Protein Expression Market (by Product), $Million, 2022-2033
  • Table 14: China Protein Expression Market (by Expression System), $Million, 2022-2033
  • Table 15: India Protein Expression Market (by Application), $Million, 2022-2033
  • Table 16: India Protein Expression Market (by End User), $Million, 2022-2033
  • Table 17: India Protein Expression Market (by Product), $Million, 2022-2033
  • Table 18: India Protein Expression Market (by Expression System), $Million, 2022-2033
  • Table 19: Australia Protein Expression Market (by Application), $Million, 2022-2033
  • Table 20: Australia Protein Expression Market (by End User), $Million, 2022-2033
  • Table 21: Australia Protein Expression Market (by Product), $Million, 2022-2033
  • Table 22: Australia Protein Expression Market (by Expression System), $Million, 2022-2033
  • Table 23: Japan Protein Expression Market (by Application), $Million, 2022-2033
  • Table 24: Japan Protein Expression Market (by End User), $Million, 2022-2033
  • Table 25: Japan Protein Expression Market (by Product), $Million, 2022-2033
  • Table 26: Japan Protein Expression Market (by Expression System), $Million, 2022-2033
  • Table 27: South Korea Protein Expression Market (by Application), $Million, 2022-2033
  • Table 28: South Korea Protein Expression Market (by End User), $Million, 2022-2033
  • Table 29: South Korea Protein Expression Market (by Product), $Million, 2022-2033
  • Table 30: South Korea Protein Expression Market (by Expression System), $Million, 2022-2033
  • Table 31: Rest-of-Asia-Pacific Protein Expression Market (by Application), $Million, 2022-2033
  • Table 32: Rest-of-Asia-Pacific Protein Expression Market (by End User), $Million, 2022-2033
  • Table 33: Rest-of-Asia-Pacific Protein Expression Market (by Product), $Million, 2022-2033
  • Table 34: Rest-of-Asia-Pacific Protein Expression Market (by Expression System), $Million, 2022-2033
  • Table 35: Market Share
目次
Product Code: BHL2241SS

Introduction to Asia-Pacific Protein Expression Market

The Asia-Pacific protein expression market was valued at $530.6 million in 2023 and is expected to reach $1,809.8 million by 2033, growing at a CAGR of 13.05% between 2023 and 2033. Protein expression is the process by which proteins are produced within cells or organisms. This involves the synthesis, modification, and regulation of proteins, all directed by genetic information stored in DNA. Proteins, with their intricate structures and diverse functions, are crucial for sustaining life and enabling various biological processes.

KEY MARKET STATISTICS
Forecast Period2023 - 2033
2023 Evaluation$530.6 Million
2033 Forecast$1,809.8 Million
CAGR13.05%

Market Introduction

The APAC Protein Expression Market is expanding rapidly, driven by significant advances in biotechnology and rising demand for recombinant proteins in a variety of applications, including research, therapeutics, and industry. Protein expression, or the process by which cells produce, fold, and assemble proteins, is critical for understanding biological functions and developing new drugs, especially in light of the increasing prevalence of chronic diseases. This demand is driving the biopharmaceutical industry to develop innovative solutions and more efficient manufacturing methods.

Technological advancements, such as cell-free protein expression systems and advanced expression vectors, are increasing protein production efficiency and yields, propelling the market forward. The APAC region is benefiting from increased investments in research and development (R&D), with major industry players focusing on launching new products and services to cater to the diverse needs of the healthcare and biotech sectors. Additionally, collaborations between academic institutions, research organizations, and biotechnology companies are fostering innovation, accelerating the translation of research into clinical applications.

Furthermore, the growing emphasis on personalized medicine, as well as the increased use of proteins in diagnostics and therapeutics, are significant drivers of market growth. With these driving forces, the APAC Protein Expression Market is poised for significant growth in the coming years, positioning it as a key player in the global biotechnology landscape.

Market Segmentation

Segmentation 1: by Application

  • Biopharmaceutical Manufacturing
  • Research and Development
  • Industrial Usage

Segmentation 2: by End User

  • Biopharmaceutical and Biotech Companies
  • CRO and CDMO
  • Academia
  • Other End Users

Segmentation 3: by Product

  • Kits and Reagents
  • Expression Vectors
  • Competent Cells
  • Plastic Consumables and Accessories

Segmentation 4: by Expression System

  • Mammalian Cell Expression System
  • Bacterial Cell Expression System
  • Insect Cell Expression System
  • Yeast Cell Expression System
  • Others

Segmentation 5: by Country

  • Japan
  • India
  • China
  • South Korea
  • Australia
  • Rest-of-Asia-Pacific

How can this report add value to an organization?

Product/Innovation Strategy: The Asia-Pacific protein expression market has been segmented on the basis of various categories, such as application, end user, offering, and expression system. Segments such as by offering have been further sub-segmented to ensure the comprehensiveness and thoroughness of the report.

Competitive Strategy: The Asia-Pacific protein expression market is a highly fragmented one, with many smaller and private companies constantly entering it. Key players in the Asia-Pacific protein expression market analyzed and profiled in the study involve established players that offer various kinds of products and services.

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, product portfolio, and market penetration.

Some prominent names established in this market are:

  • GenCefe Co., Ltd.
  • Takara Bio Inc.

Table of Contents

Executive Summary

Scope and Definition

1 Markets

  • 1.1 Trends: Current and Future Impact Assessment
    • 1.1.1 Protein Expression Market Trend Analysis
    • 1.1.2 Continuous Innovations in Fields such as Automation of Protein Expression Processes
    • 1.1.3 Advancements in Protein Engineering and Design
  • 1.2 Supply Chain Overview
    • 1.2.1 Value Chain Analysis
    • 1.2.2 Market Map
  • 1.3 Research and Development Review
    • 1.3.1 Patent Filing Trend (by Country, Year)
  • 1.4 Regulatory Landscape
  • 1.5 Impact Analysis for Key Global Events - COVID-19
  • 1.6 Market Entry Barriers and Opportunities
    • 1.6.1 Pain Points for Manufacturers
    • 1.6.2 Opportunities for Manufacturers
  • 1.7 Market Dynamics Overview
    • 1.7.1 Market Drivers
      • 1.7.1.1 Increasing Demand for Protein Biologics Creating the Need for Protein Expression
      • 1.7.1.2 Increasing Biopharmaceutical R&D Influencing the Use of Protein Expression
      • 1.7.1.3 Increasing Protein Synthesis Funding
    • 1.7.2 Market Restraints
      • 1.7.2.1 Long and Complicated Regulatory Timelines and Approvals of Recombinant Proteins and Biologics
      • 1.7.2.2 Intricate and Fluctuating Nature of Protein Expression Necessitating a Demand for Highly Trained Personnel
    • 1.7.3 Market Opportunities
      • 1.7.3.1 Advancements in Microfluidics Requiring the Use of Protein Expression
      • 1.7.3.2 Rising Awareness of Proteomics in Emerging Countries

2 Region

  • 2.1 Regional Summary
  • 2.2 Drivers and Restraints
  • 2.3 Asia-Pacific
    • 2.3.1 Regional Overview
    • 2.3.2 Driving Factors for Market Growth
    • 2.3.3 Factors Challenging the Market
    • 2.3.4 Application
    • 2.3.5 Product
    • 2.3.6 China
      • 2.3.6.1 Application
      • 2.3.6.2 Product
    • 2.3.7 India
      • 2.3.7.1 Application
      • 2.3.7.2 Product
    • 2.3.8 Australia
      • 2.3.8.1 Application
      • 2.3.8.2 Product
    • 2.3.9 Japan
      • 2.3.9.1 Application
      • 2.3.9.2 Product
    • 2.3.10 South Korea
      • 2.3.10.1 Application
      • 2.3.10.2 Product
    • 2.3.11 Rest-of-Asia-Pacific
      • 2.3.11.1 Application
      • 2.3.11.2 Product

3 Markets - Competitive Benchmarking & Company Profiles

  • 3.1 Next Frontiers
  • 3.2 Company Assessment
  • 3.3 Market Ecosystem and Key Players
    • 3.3.1 GenCefe Co., Ltd.
      • 3.3.1.1 Overview
      • 3.3.1.2 Top Services/Service Portfolio
      • 3.3.1.3 Top Competitors
      • 3.3.1.4 Key Personnel
      • 3.3.1.5 Analyst View
    • 3.3.2 Takara Bio Inc.
      • 3.3.2.1 Overview
      • 3.3.2.2 Top Products/Product Portfolio
      • 3.3.2.3 Top Competitors
      • 3.3.2.4 Key Personnel
      • 3.3.2.5 Analyst View

4 Research Methodology

  • 4.1 Data Sources
    • 4.1.1 Primary Data Sources
    • 4.1.2 Secondary Data Sources
    • 4.1.3 Data Triangulation
  • 4.2 Market Estimation and Forecast